Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion type Assertion NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_head.
- NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion description "[a significant association was observed between the MTHFR haplotype (single nucleotide polymorphisms 677 and 1298) and risk of developing therapy-related-MDS/AML in the breast cancer patients group and cyclophosphamide-treated hematological disease group]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_provenance.
- NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion evidence source_evidence_literature NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_provenance.
- NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion SIO_000772 17476281 NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_provenance.
- NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion wasDerivedFrom lhgdn-20090331 NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_provenance.
- NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_assertion wasGeneratedBy ECO_0000203 NP170911.RA9tBQ73DpSAZSSVtqzCPjJabxsc-YNVZi-6UF_4e9lzo130_provenance.